We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Halts Rusan’s Marketing Approval Over GMP Deficiencies
MHRA Halts Rusan’s Marketing Approval Over GMP Deficiencies
British authorities say serious GMP deficiencies continue to plague Rusan Pharma’s Gujarat manufacturing facility, prompting them to reject all drugs from that site until it is compliant.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor